Clinical Trials

Showing 101 - 120 of 519 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of Pomalidomide in Patients with Recurrent or Persistent Primary Central Nervous System Lymphoma or Primary Vitreoretinal Lymphoma
Relapsed/Refractory
[Protocol 14-003]
Grommes, Christian
  • Brain Tumors, Primary
    • Primary Central Nervous System Lymphoma
  • Lymphoma
A Phase I Study of PRT062070 in Patients with Persistent or Recurrent Chronic Lymphocytic Leukemia, Small Cell Lymphocytic Leukemia, or B-Cell Non-Hodgkin Lymphoma
[Protocol 14-023]
Hamlin, Paul
  • Leukemia
    • Chronic Lymphocytic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of PU-H71 in Patients with Advanced Cancer
[Protocol 11-041]
Gerecitano, John
  • Lymphoma
A Phase I Study of Ruxolitinib and Decitabine in Patients with Myeloproliferative Neoplasms in Accelerated or Blast Phase
[Protocol 14-175]
Rampal, Raajit
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Myeloproliferative Neoplasm
A Phase I Study of RXDX-101 in Patients with Locally Advanced or Metastatic Cancers Containing Alternations in the TRKA, TRKB, TRKC, ROS1, or ALK Proteins
[Protocol 14-131]
Drilon, Alexander
  • Solid Tumors
A Phase I Study of SAR405838 in Patients with Advanced Cancer
[Protocol 13-093]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
  • Solid Tumors
A Phase I Study of Selinexor (KPT-330) with Paclitaxel and Carboplatin for Treating Advanced Ovarian and Endometrial Cancers
[Protocol 14-110]
Makker, Vicky
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
  • Uterine Sarcoma
    • Carcinosarcoma
A Phase I Study of SGN-CD19A in Children and Adults with Persistent B-Cell Acute Lymphoblastic Leukemia or Aggressive Non-Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 13-106]
Trippett, Tanya
  • Leukemia
    • Acute Lymphoblastic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of SGN-CD19A in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 12-282]
Moskowitz, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia
[Protocol 13-137]
Stein, Eytan
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of SGN-LIV1A in Women with Metastatic Breast Cancer
[Protocol 14-013]
Modi, Shanu
  • Breast Cancer
A Phase I Study of Single-Dose Radiation Therapy to Treat Spine Metastases that Have Been Irradiated Before
[Protocol 14-054]
Yamada, Yoshiya
  • Spine Tumors
A Phase I Study of SNX-5422 in Patients with Advanced Lung Cancer
[Protocol 13-230]
Drilon, Alexander
  • Lung Cancer, Non-Small Cell
  • Lung Cancer, Small Cell
A Phase I Study of Stereotactic Body Radiation Therapy for Inoperable Locally Advanced Non-Small Cell Lung Cancer
Newly Diagnosed
[Protocol 13-113]
Rimner, Andreas
  • Lung Cancer, Non-Small Cell
A Phase I Study of STM 434 in Patients with Ovarian Cancer and Other Advanced Solid Tumors
[Protocol 14-132]
Hyman, David
  • Ovarian Cancer
  • Solid Tumors
A Phase I Study of TAS-102 plus CPT-11 (Irinotecan) in Patients with Advanced Digestive Cancers
[Protocol 13-105]
Saltz, Leonard
  • Colorectal Cancer
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase I Study of TAS-119 plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 14-149]
Drilon, Alexander
  • Solid Tumors
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
Relapsed/Refractory
[Protocol 12-230]
Kushner, Brian
  • Neuroblastoma
A Phase I Study of the Immune Activity and Safety of IMC-CS4 in Patients with Advanced Breast or Prostate Cancers
[Protocol 14-204]
Autio, Karen
  • Breast Cancer
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I Study of the Treatment of Beta-Thalassemia with a Gene Transfer Approach
[Protocol 10-164]
Boulad, Farid
  • Hematology
    • Hematologic Disorders
  • Pediatric Blood Disorders